Evommune publishes corporate presentation for September
Evommune, Inc. released an EX-99.1 filing containing a corporate presentation for September 2026, outlining pipeline progress for assets including EVO756, EVO301, and EVO646.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day